HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Fan Selected Research

loureirin B

5/2015Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
1/2015Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Fan Research Topics

Disease

64Neoplasms (Cancer)
09/2022 - 12/2009
46B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022 - 08/2009
26Breast Neoplasms (Breast Cancer)
06/2021 - 07/2009
20Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022 - 02/2009
19Inflammation (Inflammations)
04/2022 - 07/2007
17Lymphoma (Lymphomas)
11/2021 - 06/2012
17Carcinogenesis
01/2020 - 08/2007
15Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 12/2009
12Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 07/2008
10Neoplasm Metastasis (Metastasis)
03/2022 - 06/2011
8Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 02/2011
7Infections
06/2022 - 05/2013
7Wounds and Injuries (Trauma)
01/2022 - 10/2014
6Disease Progression
03/2022 - 10/2008
6Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 05/2018
6Colitis
12/2018 - 12/2009
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 05/2013
5Lung Neoplasms (Lung Cancer)
01/2022 - 09/2015
5Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2016
5Insulin Resistance
11/2021 - 12/2017
5Coronary Artery Disease (Coronary Atherosclerosis)
05/2021 - 12/2019
5Colitis-Associated Neoplasms
06/2017 - 12/2009
5Burns
05/2015 - 12/2011
5Leukemia
01/2014 - 06/2010
4Osteosarcoma (Osteogenic Sarcoma)
02/2022 - 06/2011
4Adenocarcinoma of Lung
01/2022 - 01/2017
4Triple Negative Breast Neoplasms
01/2022 - 01/2020
4Anemia
03/2021 - 06/2015
4Pre-Eclampsia (Preeclampsia)
01/2021 - 12/2019
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 12/2008
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015 - 05/2008
3Diarrhea
06/2022 - 12/2012
3Cytokine Release Syndrome
04/2022 - 01/2017
3Extranodal NK-T-Cell Lymphoma
10/2021 - 02/2015
3Hypoxia (Hypoxemia)
07/2021 - 01/2019
3Alzheimer Disease (Alzheimer's Disease)
04/2020 - 01/2018
3Hypertension (High Blood Pressure)
01/2020 - 10/2014

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
06/2021 - 02/2009
15Messenger RNA (mRNA)IBA
11/2021 - 02/2011
12Pharmaceutical PreparationsIBA
03/2022 - 07/2012
12MicroRNAs (MicroRNA)IBA
01/2021 - 06/2010
11Biomarkers (Surrogate Marker)IBA
03/2022 - 04/2012
10Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 08/2014
10Rituximab (Mabthera)FDA Link
12/2019 - 08/2009
9CarbonIBA
09/2022 - 02/2018
9Therapeutic UsesIBA
01/2022 - 05/2015
9Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2020 - 07/2009
8Biological ProductsIBA
04/2022 - 08/2013
8HydrogelsIBA
04/2022 - 05/2018
8CytokinesIBA
01/2022 - 05/2008
8L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2016 - 09/2009
7Indicators and Reagents (Reagents)IBA
11/2021 - 12/2010
7Immunoglobulins (Immunoglobulin)IBA
10/2021 - 10/2008
7fludarabineIBA
01/2014 - 07/2008
5Glucose (Dextrose)FDA LinkGeneric
06/2022 - 12/2017
5Peptides (Polypeptides)IBA
06/2022 - 10/2014
5Triglycerides (Triacylglycerol)IBA
01/2022 - 12/2019
5EnzymesIBA
06/2021 - 01/2012
5DNA (Deoxyribonucleic Acid)IBA
02/2021 - 01/2016
5Vitamin DFDA LinkGeneric
02/2021 - 04/2020
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 07/2008
4human ERBB2 proteinIBA
06/2021 - 01/2019
4C-Reactive ProteinIBA
05/2021 - 06/2015
4AlbuminsIBA
04/2021 - 04/2019
4HDL CholesterolIBA
03/2021 - 12/2019
4MagnesiumIBA
01/2021 - 12/2017
4salicylhydroxamic acid (SHAM)IBA
12/2020 - 12/2011
4RNA (Ribonucleic Acid)IBA
04/2020 - 06/2010
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2019 - 04/2014
4Paris saponin VIIIBA
07/2019 - 03/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2014
4Polysaccharides (Glycans)IBA
12/2018 - 10/2013
4Dextrans (Dextran)FDA Link
10/2017 - 03/2014
3Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 12/2010
3Small Interfering RNA (siRNA)IBA
04/2022 - 06/2011
3polydopamineIBA
04/2022 - 10/2020
3polypyrroleIBA
03/2022 - 11/2018
3PolymersIBA
01/2022 - 11/2018
3CollagenIBA
01/2022 - 10/2014
3Histone Deacetylase InhibitorsIBA
01/2022 - 07/2015
3ChemokinesIBA
01/2022 - 01/2013
3fibrin fragment D (D-dimer)IBA
12/2021 - 01/2020
3LipidsIBA
11/2021 - 01/2019
3Oxidoreductases (Dehydrogenase)IBA
06/2021 - 07/2009
3Hormones (Hormone)IBA
06/2021 - 08/2013
3CholesterolIBA
03/2021 - 10/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 01/2020
3Caspase 3 (Caspase-3)IBA
12/2020 - 11/2010
3Glutathione (Reduced Glutathione)IBA
10/2020 - 08/2018
3Circular RNAIBA
03/2020 - 01/2019
3Fibrinogen (Factor I)FDA Link
01/2020 - 06/2015
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 - 02/2015

Therapy/Procedure

51Therapeutics
09/2022 - 08/2009
20Drug Therapy (Chemotherapy)
10/2021 - 12/2008
6Photothermal Therapy
09/2022 - 02/2018
5Percutaneous Coronary Intervention
05/2021 - 12/2019
4Adjuvant Chemotherapy
06/2021 - 01/2012
4Transplantation
04/2019 - 12/2008
3Immunotherapy
01/2022 - 06/2015
3Neoadjuvant Therapy
01/2021 - 05/2016